PSUSA/00010348/202409
PSUSA/00010348/202409
PSUSA/00010348/202409
Human medicines European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya), clopidogrel, Date of authorisation: 20/09/2009, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Clopidogrel TAD, clopidogrel, Date of authorisation: 23/09/2009, Revision: 17, Status: Authorised
EMEA-002876-PIP02-23
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 11, Status: Authorised
EMEA-002689-PIP02-23
EMEA-003176-PIP02-22
European Shortages Monitoring Platform (ESMP) essentials: Industry and network reporting requirements
European Shortages Monitoring Platform (ESMP) Informational brief
Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026